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Summary
Background: The clinical picture in Parkinsons disease (PD) is characterized by
bradykinesia, rigidity, resting tremor and postural instability. In advanced stages of
the disease, many patients will experience reduced efficacy of medication with
fluctuations in symptoms and dyskinesias. Surgical treatment with deep brain
stimulation in the subthalamic nucleus (STN-DBS) is now considered the gold
standard in fluctuating PD. Many patients experience a gain of weight following the
surgery. The aim of this study was to identify possible mechanisms, which may
contribute to body weight gain in patients with PD following bilateral STN-DBS
surgery.
Methods: Ten patients with PD were studied before bilateral STN-DBS surgery, and
seven patients were studied again 3 and 12 months postoperatively. Clinical
examination and resting metabolic rate with and without medical treatment was
measured before and after STN-DBS. Furthermore, free-living energy expenditure,
body composition, energy intake, peak oxygen consumption, maximal workload
and leisure time physical activity were measured before and 3 and 12 months after
surgery.
Results: The STN-DBS operated patients had a significant weight gain of 4Æ7 ± 1Æ6 kg
(mean ± SE) 12 months postoperatively, and the weight gain was in the fat mass.
The free-living energy expenditure decreased postoperatively 13 ± 4% even though
the reported dietary intake was reduced. A decreased energy expenditure took place
in the non-resting energy expenditure. The reported daily leisure time activity, peak
oxygen consumption and maximal workload were unchanged.
Conclusion: The STN-DBS operated patients have a significant postoperative weight
gain, as a result of a decrease in free-living energy expenditure concomitant with an
insufficient decrease in energy intake.
Introduction
Parkinsons disease (PD) is a progressive neurologic disorder,
which mainly affects the nigrostriatal system. The four cardinal
signs in PD are bradykinesia, rigidity, resting tremor and
postural instability. Dopaminergic therapies such as levodopa or
dopamine agonists usually improve symptoms and signs very
effectively in the first 5–7 years. However, the progression of
disease is inevitable, and after years in medical treatment, many
patients will experience reduced efficacy of medication.
The introduction of deep brain stimulation (DBS) of the
subthalamic nucleus (STN) in the treatment of advanced,
fluctuating parkinsonism has altered the treatment of late-stage
PD dramatically and is now considered the most effective
surgical procedure for patients with PD and intractable
fluctuations (Krack et al., 2003). The treatment leads to a great
reduction in on-off phenomena and a large improvement of
L-dopa-induced dyskinesias as the anti-parkinsonian medication
can be reduced considerably. Many patients experience a large
gain of weight in the period following the implantation of DBS
devices, where most of the studies on weight gain have focused
on bilateral STN stimulation (Barichella et al., 2003; Macia et al.,
2004; Perlemoine et al., 2005; Tuite et al., 2005; Montaurier
et al., 2007; Walker et al., 2009b; Strowd et al., 2010; Locke
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et al., 2011) However, weight gain has also been described after
unilateral STN stimulation and globus pallidus internus DBS
(Walker et al., 2009a; Locke et al., 2011).Some of these patients
had a low weight beforehand, so their gain has normalized the
weight; others develop overweight (Barichella et al., 2003;
Macia et al., 2004). In patients with documented weight gain
postoperatively, the gain has been correlated with reduction in
hyperkinesias (Romito et al., 2002). Subsidence of chronic
tremor could cause decreased energy expenditure (Tuite et al.,
2005). Macia et al. (2004) found a postoperative decrease in
energy expenditure, especially for patients with many fluctua-
tions and dyskinesias preoperatively, and the postoperative
weight gain was correlated with reduction in L-dopa doses.
However, a stimulatory effect on the metabolic rate of DBS
cannot be excluded.
The aim of this study was to identify possible mechanisms
that may contribute to body weight gain in patients with PD
following bilateral STN-DBS. We therefore measured body
composition, free-living energy expenditure, energy intake and
resting metabolic rate in a group of patients pre- and
postoperatively. Furthermore, the resting metabolic rate was
measured with and without medical treatment and DBS.
Material and methods
Subjects
The study enrolled 10 patients with PD (seven men) who
were operated with bilateral STN-DBS. Mean (SD) history of
disease was 13Æ3 (4Æ8) years, and they all suffered from severe
motor fluctuations that were not improved by changes in their
anti-parkinsonian medication. Mean (SD) age was 61Æ7
(6Æ5) years. The patients were approved for surgery according
to following selection criteria (Defer et al., 1999): disease
duration >5 years, age under 70 years, excellent response to
apo-morphine or levodopa challenge, no surgical contraindi-
cations, and no dementia or major ongoing psychiatric illness.
Of these patients, one got a cerebral haemorrhagia during
surgery and one patient did not wish to continue follow-up
after surgery. One patient died 10 months after the STN-DBS
surgery (complication to pneumonia). Seven patients com-
pleted the whole study, which included a pretest and a 3- and
12-month follow-up after surgery. The subjects were given a
written and oral description of the study before giving their
voluntary consent to participate. The Scientific Ethical Com-
mittees of The Capital Region approved the study (project nr
KF(01)259416).
Study design
Patients were studied before and again 3 and 12 months after
STN-DBS surgery.
The following same measurements were taken over a 4-day
period: On day 1, a clinical examination and an interview on
health and medical history were performed. Body composition,
peak oxygen consumption and leisure time physical activity
were measured. In the morning on day 2–4, resting energy
expenditure (REE) was measured. In the following 14 days, the
free-living energy expenditure was measured.
Unified Parkinsons Disease Rating Scale
Following the test, evaluation of signs of PD was performed
using the motor component of the Unified Parkinsons Disease
Rating Scale (UPDRS), which includes assessment of general
bradykinesia, rigidity (neck, arms, legs) and tremor (face,
hands, feet, action tremor) (Ramaker et al., 2002; Goetz et al.,
2008). UPDRS III was performed before surgery in best ON
with medication and without medication after withdrawal
overnight (OFF). After surgery, UPDRS III was performed at
three and 12 months, on three consecutive days: without
medication and without STN-DBS stimulation (off stimulation,
off medication), with STN-DBS stimulation but without anti-
parkinsonian medication (on stimulation, off medication) and
with STN-DBS stimulation and with anti-parkinsonian medica-
tion (on stimulation, on medication).
Stage of disease (Hoehn and Yahr) was assessed (Goetz et al.,
2004).
Body composition
Patients fat mass and fat-free mass (FFM) were determined by
DEXA-scanning (Lunar DPX-IQ, software version 4.6c; Lunar
Corporation, Madison, WI, USA).
Resting energy expenditure
In the evening before measurement, the anti-parkinsonian
medication was paused at 20:00, and the next morning (day
2) REE was determined by indirect calorimetry in the resting
and fasting (12 h) condition (defined off medication). On
day 3 in the morning, REE was determined again, but where
the patients were on their normal anti-parkinsonian medica-
tion (on medication). Oxygen consumption and carbon
dioxide output were measured continuously with an Oxycon
Champion System using facemask and the breath-by-breath
technique for a period of 30–45 min. Values for REE and
substrate oxidation rates were calculated from the oxygen
consumption and the respiratory exchange ratio (RER)
(Ferrannini, 1988). Protein oxidation was assumed to be
60 g day)1, corresponding to about 15% of basal metabolic
rate (Perlemoine et al., 2005).
The measurements of REE performed 3 and 12 months after
STN-DBS surgery were as follows: on day 2 without
medication and without STN-DBS stimulation (off stimula-
tion, off medication), on day 3 with STN-DBS stimulation
but without anti-parkinsonian medication (on stimulation,
off medication) and on day 4 with STN-DBS stimulation and
with anti-parkinsonian medication (on stimulation, on
medication).
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Non-resting energy expenditure
Non-resting energy expenditure was calculated as the total
energy expenditure during free living minus REE during on
medication and postoperatively on medication and on
stimulation.
Total daily energy expenditure
Free-living daily energy expenditure (DEE) was determined over
a 14-day period using the doubly labelled water technique while
the patients consumed their usual prescribed medication and
after surgery with STN-DBS stimulation. Baseline urine samples
were obtained for background measurements, and an oral dose
of 2H2O (0Æ125 g kg
)1 estimated body water) and H2
18O
(0Æ25 g kg)1 estimated body water) was administered in the
evening of day 2. Two urine samples were obtained the
following morning and 7 and 14 days later (morning urine)
(Westerterp et al., 1995). The urine samples were stored at
)20C until analysis took place. The isotopes deuterium (2H)
and oxygen-18 (18O) in the urine were analysed by isotope
ratio mass spectrometry (Optima; VG Isogas Ltd, Middlewich,
Cheshire, UK). The carbon dioxide (CO2) production rate was
calculated from the elimination rates of the two stable isotopes
using the equation of Schoeller (1988). The respiratory quotient
(RQ) was taken to be equal to the food quotient of the diet and
was taken as 0Æ85 (Black et al., 1986). The energy expenditure
was calculated based on the carbon dioxide production rate and
RQ.
Peak oxygen consumption
Peak oxygen consumption was determined by indirect calorim-
etry (Oxycon Champion; Jaeger, Wuerzburg, Germany). The
subjects exercised on an electrically braced cycle ergometer
(ergometrics er900; ergoline, Bitz, Germany). The initial
workload was 30 W and was increased by 30 W every 2 min
until exhaustion. Oxygen uptake and carbon dioxide output
were measured using facemask and the breath-by-breath
technique.
Energy intake
Energy intake was determined from a 3-day food diary. Patients
were provided with a dietary scale and instructed on the
measurement of food intake. The patients were strongly
encouraged not to change their dietary habits during the
measurement period. The calculation was performed in http://
www.madlog.dk. The energy intake was measured during the
doubly labelled water measurement period.
Leisure time physical activity
The level of physical activity spent by the patients over a 7-day
period was scored using a questionnaire for elderly. The
questionnaire scores the activity level with regard to leisure
time, household and work-related activity. Scores were calcu-
lated according to the PASE Administration and Scoring
Instruction manual (Washburn et al., 1993).
Statistical analysis
All data from experiments are given as mean ± SEM. The data
were analysed by a paired t-test for each time point. P<0Æ05 was
considered significant.
Results
The staging scale as measured by the Hoehn and Yahr was
2Æ3 ± 0Æ1 at enrolment and did not change during the study.
Preoperative
Physical characteristics of the 10 enrolled patients are shown in
Table 1. Furthermore, the parkinsonian symptoms and REE with
and without anti-parkinsonian medication are shown. There was
a significantly increased resting oxygen uptake with the patients
off drug compared with on drug, and a non-significant
increased REE off drug compared with on drug (P = 0Æ065),
while RER was unchanged.
Seven patients fulfilled the whole follow-up period, and the
following postoperative results are from these seven patients.
Parkinsonian symptoms
There was, as expected, a significant improvement in UPDRS III
and IV after surgery (data not shown). Anti-parkinsonian
medication was reduced postoperatively; however, it did not
Table 1 Physical characteristics, parkinsonian symptoms and resting
energy expenditure in the 10 preoperative patients on and off their
anti-parkinsonian medication.
N = 10 Preoperative
Height (cm) 174Æ0 ± 2Æ3
Body weight (kg) 78Æ1 ± 3Æ1
BMI (kg m)2) 25Æ8 ± 0Æ7
Fat mass (kg) 20Æ7 ± 1Æ7
Fat mass (%) 27Æ7 ± 2Æ3
Fat-free mass (kg) 57Æ4 ± 3Æ1
UPDRS III on drug 19Æ6 ± 3Æ1
UPDRS III off drug 41Æ4 ± 3Æ4*
UPDRS IV on drug 7Æ3 ± 0Æ6
L-dopa equivalent dose (mg day)1) 878 ± 118
Resting oxygen uptake (ml min)1) on drug 272 ± 12
Resting oxygen uptake (ml min)1) off drug 304 ± 12*
Respiratory exchange ratio on drug 0Æ74 ± 0Æ01
Respiratory exchange ratio off drug 0Æ72 ± 0Æ01
Resting energy expenditure on drug (MJ day)1) 7Æ7 ± 0Æ4
Resting energy expenditure off drug (MJ day)1) 8Æ6 ± 0Æ4
Mean ± SEM. *P<0Æ05 (pared t-test) compared with measurement on
anti-parkinsonian medication.
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reach significance (P = 0Æ064 after 3 months and P = 0Æ072
after 12 months) (Table 2).
Body composition
There was a significant increase in body weight at 4Æ7 kg (range
2Æ0–11Æ5 kg) 12 months after the operation, and the increase
took place in the fat mass whereas the FFM was unchanged
(Table 2).
Resting energy expenditure
During anti-parkinsonian medication was the preoperative
resting oxygen consumption (VO2) 283 ± 13 ml min
)1, the
REE 8Æ00 ± 0Æ3 MJ day)1 and the RER 0Æ75 ± 0Æ2, and these
parameters did not change significantly on drug ⁄ on stimu-
lation 3 and 12 months postoperatively. In Fig. 1 is shown the
VO2, REE and RER 3 and 12 months after surgery.
Three and 12 months after operation, there were no
significant differences in VO2 and REE comparing values on
drug ⁄ on stimulation with values off drug ⁄ off stimulation
and off drug ⁄ on stimulation (Fig. 1). However, during STN-
DBS stimulation, the RER was significantly increased compared
with off drug ⁄ off stimulation three and 12 months after
surgery (Fig. 1).
Substrate oxidation rates
The substrate oxidation rates after surgery is shown in Fig. 2.
Preoperatively, there was no significant difference in fasting
carbohydrate oxidation or lipid oxidation during anti-parkinso-
nian medication (on drug) compared with off drug (data not
shown). After the operation, the resting fasting lipid oxidation
decreased significantly when the patients were on stimulation
compared with off drug ⁄ off stimulation at both 3 and
12 months visit (Fig. 2).
Daily energy expenditure
The DEE is shown in Table 3. The free-living DEE decreased,
although not significantly 3 months after surgery (P = 0Æ053)
and was significantly decreased with 13 ± 4% 12 months
after the operation compared with the preoperative value
(Table 3).
Non-resting energy expenditure
The non-resting energy expenditure is the amount of the DEE
not coming from REE when the patients are on medication and
postoperatively on medication and on stimulation. It was
significantly decreased by 42 ± 9% 3 months after surgery and
by 41 ± 8% 12 months after surgery compared with the
preoperative value (Table 3).
Daily energy intake
The reported daily energy intake (DEI) decreased significantly
12 months after the operation compared with preoperative
values (Table 3). The reported DEI accounted for about 70% of
the DEE.
Table 2 Body composition and anti-parkinsonian medication before
and after deep brain stimulation in the subthalamic nucleus surgery.
N = 7 Preoperative 3 months after 12 months after
L-dopa equivalent
dose (mg day)1)
873 ± 108 551 ± 99 598 ± 91
Body weight (kg) 79Æ4 ± 4Æ4 82Æ7 ± 3Æ9 84Æ1 ± 3Æ7*
BMI (kg m)2) 25Æ5 ± 0Æ9 26Æ5 ± 0Æ8 27Æ0 ± 0Æ8*
Fat mass (kg) 19Æ6 ± 1Æ9 22Æ6 ± 2Æ3* 23Æ5 ± 2Æ5*
Fat mass (%) 25Æ7 ± 2Æ1 28Æ4 ± 2Æ7* 29Æ0 ± 2Æ9
Fat-free mass (kg) 59Æ8 ± 3Æ7 60Æ1 ± 3Æ6 60Æ6 ± 3Æ2
Mean ± SEM. *P<0Æ05 (pared t-test) compared with preoperative val-
ues.
Resting energy expenditure








































Figure 1 Whole-body fasting oxygen consumption, resting
energy expenditure and respiratory exchange ratio 3 and 12 months
after the deep brain stimulation in the subthalamic nucleus (STN-DBS)
surgery: Open bars are with the patients on DBS and on their anti-
parkinsonian medication. Closed bars are with the patients without DBS
and without their anti-parkinsonian medication for 12 h. Hatched bars
are with the patients without their anti-parkinsonian medication for
12 h but during DBS.
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Peak oxygen uptake and maximal workload
The peak oxygen uptake and maximal workload is shown in
Table 3. There was no difference in peak oxygen uptake or
maximal workload during the study period.
Leisure time physical activity
The physical activity score did not change significantly 3 or
12 months after surgery (Table 3).
Discussion
This study is the first long-term prospective study, where free-
living energy expenditure has been extensively evaluated before
and 3 and 12 months after STN-DBS surgery. All patients
experienced a much better motor performance similar to
previously reported studies with effect on levodopa-responsive
perkinsonian features such as bradykinesia, tremor and rigidity
with a reduction in the need for anti-parkinsonian medication
(Limousin et al., 1998; Moro et al., 1999).
The main finding is that the STN-DBS operated patients had a
significant weight gain postoperatively and that the weight gain
was taking place in the fat mass. This is in agreement with a
recent study (Bannier et al., 2009), where patients were
examined before and 3 and 16 months after STN-DBS operation.
The increase in weight was attributed to a decrease in total
energy expenditure concomitant with an insufficient decrease in
energy intake. Furthermore, the decrease in total energy
expenditure was taking place in the non- REE.
During weight stable conditions, the energy intake is equal to
the energy used (total energy expenditure). If an individual is in
positive energy balance, there will be a weight gain because of
storing of energy.
The decrease in total energy expenditure after surgery in the
present study was about 2 MJ day)1, which theoretically would
led to a weight gain at about 20 kg after 1 year assuming
unchanged daily caloric intake postoperatively, and all the extra
energy deposited as fat.
Only very few earlier studies have measured free-living
energy expenditure in patients with PD using the doubly
labelled water technique (Toth et al., 1997; Delikanaki-Skaribas
et al., 2009). The mean DEE in these studies was about 25%
lower than in the present study. However, in these studies they
investigated patients on levodopa medication without severe
dyskinesias. Therefore, this discrepancy can be explained by
difference in weight, age and severe dyskinesias as our patients
were candidates for operation.
An earlier study (Montaurier et al., 2007) has measured the
effect of STN-DBS on the DEE evaluated in a calorimetric
chamber before and 3 months after surgery. They found a
significant reduction by about 9%, and although this result was
under controlled conditions, it is in accordance with the present
results. Furthermore, they found unchanged REE 3 months
postoperatively in accordance with the results in the present
study, where the REE with the patients on anti-parkinsonian
medication and on brain stimulation did not change three and
12 months after STN-DBS surgery. In two earlier studies (Toth
et al., 1997; Delikanaki-Skaribas et al., 2009), REE was measured
during indirect calorimetry. In these studies, they found a value
about 20% lower than that found in the present study. Increased
rigidity, dystonia and tremor with more severe PD in our study
may account for the higher REE in comparison with these other
studies.
To investigate whether the medication or the brain stimula-
tion per se after surgery influences the REE, we measured the REE
3 months after surgery
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Figure 2 Whole-body fasting substrate oxidation rates 3 and
12 months after the deep brain stimulation in the subthalamic
nucleus (STN-DBS) surgery: Open bars are with the patients on DBS and
on their anti-parkinsonian medication. Closed bars are with the patients
without DBS and without their anti-parkinsonian medication for 12 h.
Hatched bars are with the patients without their anti-parkinsonian
medication for 12 h but during DBS.
Table 3 Daily free-living energy expenditure (DEE), non-resting
energy expenditure (non-REE), reported daily energy intake (DEI), peak
oxygen uptake, maximal workload and reported physical activity (PASE)
before and after deep brain stimulation in the subthalamic nucleus
surgery.





DEE (MJ day)1) 13Æ3 ± 1Æ1 11Æ4 ± 0Æ6 11Æ3 ± 0Æ6*
Non-REE (MJ day)1) 5Æ2 ± 0Æ9 2Æ7 ± 0Æ4* 2Æ9 ± 0Æ5*
DEI (MJ day)1) 10Æ1 ± 1Æ0 8Æ6 ± 1Æ1 8Æ0 ± 0Æ6*
Peak VO2 (l min
)1) 2Æ4 ± 0Æ4 2Æ4 ± 0Æ4 2Æ4 ± 0Æ2
Peak VO2 (ml kg
)1 min)1) 30 ± 4 28 ± 3 28 ± 2
Maximal workload (W) 138 ± 27 146 ± 22 139 ± 15
PASE 174 ± 25 148 ± 12 159 ± 26
Mean ± SEM. *P<0Æ05 (pared t-test) compared with preoperative val-
ues.
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during different situations in the two postoperative measure-
ments (Fig. 1). We found that the REE was not significantly
different during off medication and off stimulation compared
with the values on medication and on stimulation. This is in
contrast to the results by others (Perlemoine et al., 2005;
Montaurier et al., 2007), but the discrepancy is probably due to
differences in the two studies as the other study investigated the
patients during acute L-dopa challenge and acute brain stimu-
lation (30 min), while in our study the off ⁄ off measurements
were performed after the stimulation, and anti-parkinsonian
medication was removed for 12 h before the measurements.
The present study also showed that the DBS per se significantly
decreased the lipid oxidation rate during on stimulation. This
change in substrate oxidation rate has been observed by others
(Perlemoine et al., 2005). There is no obvious explanation for
the shift in substrate oxidation rates. However, measurements
on rats after 30 s of electrical stimulation of the hypothalamus
showed increases in energy expenditure and increases in RER,
suggesting that the hypothalamic activity influences which
substrate the rat uses for energy and that hypothalamus forms
part of body weight regulation (Atrens et al., 1987).
The reported daily physical activity level and the fitness as
measured by peak oxygen uptake were unchanged postopera-
tively. The patients improved their motor function postopera-
tively (UPDRS III), and in general these patients improve their
physical activity so it cannot be excluded that the scale used has
a too low sensitivity in this type of patients, or the number of
subjects was too low. On the other hand, all the investigated
patients increased their body weight postoperatively.
Under-reporting of food intake is frequent and has earlier
been shown by the doubly labelled water method (Schoeller,
1990; Trabulsi & Schoeller, 2001; Ferriolli et al., 2010). In an
earlier review, they found about 25% under-reporting under
different conditions. In our study, the under-reporting was
about 25% and not significantly different in the pre- and
postoperative period. The reported dietary intake was signif-
icantly decreased at 12 months postoperatively in spite of
weight gain in the same period. This suggest that the positive
weight balance postoperatively in the STN-DBS patients is not
because of increased appetite and thereby increased energy
intake as proposed in an earlier abstract by Barichella et al.
(2002). Nevertheless, in a later article from the same group
they found that the weight gain after STN-DBS operation was
independent of increase in appetite and therefore an unlikely
explanation (Barichella et al., 2003), which has been con-
firmed by other prospective studies (Montaurier et al., 2007;
Sauleau et al., 2009). However, inaccuracy of self-reported
intakes should prompt caution in the interpretation of the
result.
The study has shown that the DEE decreases after STN-DBS
surgery, so a likely explanation of the weight gain is that brain
stimulation induces an imbalance between energy intake and
energy expenditure. It can be speculated whether STN DBS per se
has a central weight modifying effect, as proposed in recent
studies (Strowd et al., 2010; Locke et al., 2011). The expected
postoperative weight gain can be prevented by nutritional
intervention starting up early after the operation if weight gain
is not welcome (Guimaraes et al., 2009).
The patients were in positive energy balance during the study,
and the indirect measurements of energy expenditure assume
steady state. However, the measurements of free-living energy
expenditure were taken during 14 days, and in this period, the
weight gain was on average 0Æ2 kg. This will only influence the
RQ and energy equivalent of carbon dioxide with <1% (Elia,
1991).
Limitations
This study is one of the few long-term prospective studies
where energy intake and energy expenditure have been
extensively evaluated before and after STN-DBS. However, the
number of patients is limited, so there can be risk of type 2
statistical errors.
Conclusion
The STN-DBS operated patients have a significant postoperative
weight gain, and the weight gain is taking place in the fat mass.
The increase in weight is attributed to a decrease in free-living
energy expenditure concomitant with a simultaneous insuffi-
cient decrease in energy intake. The marked changes in free-
living DEE observed after STN-DBS operation in Parkinson
patients may have important implications in terms of practical
and clinical recommendations for reducing energy intake if
weight gain is not welcome postoperatively.
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